Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H5O7.Ga |
| Molecular Weight | 256.0279 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[67Ga+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI
InChIKey=YEEGWNXDUZONAA-RYDPDVNUSA-K
InChI=1S/C6H8O7.Ga/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3/i;1-3
| Molecular Formula | Ga |
| Molecular Weight | 66.928204915 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H5O7 |
| Molecular Weight | 189.0997 |
| Charge | -3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Gallium citrate Ga 67 is the citrate salt of the radioisotope gallium Ga 67. Although the mechanism is unknown, gallium Ga 67 concentrates in lysosomes and is bound to a soluble intracellular protein in certain viable primary and metastatic tumors and focal sites of inflammation, allowing scintigraphic localization. Ga-67 scintigraphy (GS) cannot differentiate between tumor and acute inflammation. Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | GALLIUM CITRATE GA 67 Approved UseGallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. Launch Date1976 |
|||
| Primary | GALLIUM CITRATE GA 67 Approved UseGallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. Launch Date1976 |
|||
| Primary | GALLIUM CITRATE GA 67 Approved UseGallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. Launch Date1976 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:41:07 GMT 2025
by
admin
on
Wed Apr 02 07:41:07 GMT 2025
|
| Record UNII |
4LJK511Z86
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QV09HX01
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
||
|
NCI_THESAURUS |
C1446
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
||
|
NDF-RT |
N0000000205
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
||
|
NDF-RT |
N0000177914
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
||
|
WHO-ATC |
V09HX01
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
272758
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
DTXSID70194107
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
255-248-4
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
Gallium Citrate Ga 67
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
m5649
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | Merck Index | ||
|
41183-64-6
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
4560
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
1546372
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
ALTERNATIVE | |||
|
DB06784
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
100000090307
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
SUB02307MIG
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
65430
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
4LJK511Z86
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110553
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
SUB07873MIG
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
3744
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
4LJK511Z86
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY | |||
|
C47547
Created by
admin on Wed Apr 02 07:41:07 GMT 2025 , Edited by admin on Wed Apr 02 07:41:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
||
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|